Your browser doesn't support javascript.
loading
DIALIZE China: A Phase IIIb, Randomized, Placebo-Controlled Study to Reduce Predialysis Hyperkalemia With Sodium Zirconium Cyclosilicate in Chinese Patients.
Ni, Zhaohui; Lu, Renhua; Xu, Xudong; Bian, Xueyan; Zhou, Zhihong; Yang, Junwei; Luo, Qun; Chen, Menghua; Chen, Chaosheng; Sun, Xiuli; Yu, Lei; He, Qiang; Jiang, Hong; Yuan, Weijie; Li, Yi; Zhou, Rong; Wang, Jianqin; Zhang, Xinzhou; Zuo, Li; Meng, Xiangwen; Chang, Zhiren; Zhao, June; Wessman, Peter; Xiang, Peng.
Affiliation
  • Ni Z; Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: profnizh@126.com.
  • Lu R; Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Xu X; Central Hospital of Minhang District, Shanghai, China.
  • Bian X; Ningbo First Hospital, Ningbo, China.
  • Zhou Z; The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Yang J; The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Luo Q; Ningbo Huamei Hospital, University of Chinese Academy of Sciences, Ningbo, China.
  • Chen M; General Hospital of Ningxia Medical University, Yinchuan, China.
  • Chen C; The First Affiliated Hospital of Wenzhou College, Wenzhou, China.
  • Sun X; Baotou City Central Hospital, Baotou, China.
  • Yu L; Inner Mongolia People's Hospital, Hohhot, China.
  • He Q; Zhejiang Traditional Chinese Medicine Hospital, Hangzhou, China.
  • Jiang H; People's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang, China.
  • Yuan W; Shanghai General Hospital, Shanghai, China.
  • Li Y; Dongguan People's Hospital, Dongguan, China.
  • Zhou R; Shanghai Yangpu District Central Hospital, Shanghai, China.
  • Wang J; Lanzhou University Second Hospital, Lanzhou, China.
  • Zhang X; Shenzhen People's Hospital, Shenzhen, China.
  • Zuo L; Peking University People's Hospital, Beijing, China.
  • Meng X; Global R&D (China), AstraZeneca, Shanghai, China.
  • Chang Z; Global R&D (China), AstraZeneca, Beijing, China.
  • Zhao J; BioPharmaceuticals Clinical, AstraZeneca R&D, Gaithersburg, Maryland.
  • Wessman P; BioPharmaceuticals Clinical, AstraZeneca R&D, Gothenburg, Sweden.
  • Xiang P; Global R&D (China), AstraZeneca, Shanghai, China.
Clin Ther ; 45(7): 633-642, 2023 07.
Article in En | MEDLINE | ID: mdl-37385905
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Renal Dialysis / Hyperkalemia / Kidney Failure, Chronic Type of study: Clinical_trials / Etiology_studies / Prognostic_studies Limits: Adult / Aged / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: Clin Ther Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Renal Dialysis / Hyperkalemia / Kidney Failure, Chronic Type of study: Clinical_trials / Etiology_studies / Prognostic_studies Limits: Adult / Aged / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: Clin Ther Year: 2023 Document type: Article